pharmacoepigenomics
The company is seeing its CYP2C19 test adopted broadly as it prepares to submit a new application to the FDA for an assay targeting neurodegenerative disease.
Invitae Acquires Three Companies: YouScript, Genelex, Diploid
Invitae said YouScript and Genelex will enable it to provide pharmacogenomic testing, while Diploid will help interpret WGS results.
The study sequenced the genomes of 300 deceased patients and found many variants consistent with diseases and adverse drug events the patients encountered during their lives.
UCB Canada Joins C$10.8M Epilepsy PGx Development Initiative
NEW YORK (GenomeWeb News) – UCB Canada said today it will support a multi-partner research project funded by Genome Canada and Genome Quebec by helping to study the genomes of epilepsy patients and analyzing genes involved in their responses to medications.
A new partnership between diagnostics manufacturer MDxHealth and Ghent University's laboratory of pharmaceutical biotechnology aims to develop epigenomics-based diagnostics for more personalized treatment of cancers and inflammatory diseases.